By: 8 March 2018
Do pain medications carry different heart risks?

Prior studies have suggested that non-steroidal anti-inflammatory drugs (NSAIDs) may be linked with higher cardiovascular risks, but few have assessed potential different cardiovascular risk between NSAID classes or across individual NSAIDs.

A British Journal of Clinical Pharmacology study on pain medication, including 55,629 patients with hypertension in a Taiwanese database did not observe different cardiovascular risks in patients who received cyclooxygenase-2 enzyme selective NSAIDs or nonselective NSAIDs during four weeks of follow-up.

The study also found no apparent difference in cardiovascular risk when comparing celecoxib with diclofenac, ibuprofen, or naproxen, although a significantly increased risk was observed when comparing celeocxib with mefenamic acid.

“Our results provide important information about the comparative safety of alternative NSAID use in patients with hypertension in real-world settings. Under low-to-moderate daily dose and a short-term treatment period, most commonly used NSAIDs have similar cardiovascular safety profiles,” said co-author Dr. Chia-Hsuin Chang, of the National Taiwan University Hospital.

Source: Wiley

Reference: Yaa-Hui Dong, PhD; Chia-Hsuin Chang, MD; Li-Chiu Wu, MS; Jing-Shiang Hwang, PhD and Sengwee Toh, ScD. Comparative cardiovascular safety of non-steroidal anti-inflammatory drugs in patients with hypertension: a population-based cohort study. British Journal of Clinical Pharmacology. DOI: 10.1111/bcp.13537.